Evoke Pharma, Inc.
Evoke Pharma, Inc. (EVOK) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · EVOK · as of Jun 9, 2026
Key Statistics
Explore Evoke Pharma, Inc. Data
evok stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 12 · Buy rate: 75.0%
The EVOK analyst consensus is Buy, based on ratings from 12 Wall Street analysts over the past 3 months. The average 12-month price target is $18.00, representing +63.64% upside from the current price of $11.00.
Competitors & Peers
evok competitorsEVOK
ADIL
BFRI
BMRA
MHUA
NRSNStock Performance
Full HistoryAbout Evoke Pharma, Inc.
Evoke Pharma, Inc. operates as a specialized pharmaceutical entity, primarily focused on inventing and bringing to market therapeutic agents for various digestive system illnesses. The company's lead …
what is evoke pharma, inc. · evok stock overview · evoke pharma, inc. company profile · who is evoke pharma, inc. ceo · evok NASDAQ · evoke pharma, inc. headquarters · evoke pharma, inc. business segments
About Stock Overview & Key Data
Evoke Pharma, Inc. (EVOK) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since Sep 25, 2013. As of the latest trading session, EVOK stock price is $11.00, with a market capitalization of $18.9M. The stock has returned +146.64% over the past 12 months and +0.00% year-to-date.
According to 12 Wall Street analysts, the consensus rating for Evoke Pharma, Inc. stock is Buy, with an average 12-month price target of $18.00. In fiscal year 2024, Evoke Pharma, Inc. reported revenue of $10.2M and net income of -$5.4M. For detailed data — including Evoke Pharma, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Evoke Pharma, Inc. (EVOK) stock price is $11.00. The stock is traded on NASDAQ under the ticker symbol EVOK. The 52-week range is $1.94 – $11.00.